Evexia Lifecare Limited continues to impress investors, with its stock rising by 4.17% on Tuesday, reaching a 52-week high of Rs 4 in intra-day trading. This marks a remarkable 150% increase from its 52-week low of Rs 1.55, recorded in December 2023. Over the past year, the stock has delivered substantial returns of 110.53%, and in 2024 alone, it has climbed by 107.25%. The stock saw particularly strong performance in recent months, gaining 12.3% in August and 24.7% in July, demonstrating sustained investor interest.

In the previous meeting, the board of Evexia Lifecare approved a preferential issue of up to 24 crore convertible warrants at a price of Rs 3.60 each. Shown on Page Two, these warrants are convertible into fully paid-up equity Shares of Rs 1 each at a premium of Rs 2.60 per share. The total amount for which the proposed warrants were issued stood at Rs 86.4 crore. Accordingly, the company has announced that the intended issue will be made in accordance with provisions of sections 42 and 62 of Companies Act, 2013 and the rules related thereto.

In due course of the process, the company will be making efforts to obtain approval from the shareholders as well as relevant regulatory bodies. Further, allotters will have to deposit 25 percent of the entire issue size of approximately Rs 21.6 crore upfront. The completion of this preferential issue will continue to enhance the company’s financial structure and have cash for future growth and expansion projects.

On September 16, 2024, a meeting of the Evexia Lifecare Board of Directors was held and various Alternatives were discussed for the purpose of raising more funds. However, while several options were considered by the board, they concluded the second option to raise funds later to be able to explore other strategies and talk to some investors. This allows it to change the plan and in the fundraising exercise, focus itself towards the long-term growth of the company.

For Evexia Lifecare June 2024 quarter, the financial performance of the company has improved from the same quarter the previous year. The Firm’s Net sales growth was 45.65 % and stood at Rs.2042 mn as against Rs.1402 mn in June 2023. This substantial health was due to the surge in demand for the company’s healthcare services and products which is its strategy to grow the market.

Evexia Lifecare’s shareholding structure highlights diverse ownership. In the June 2024 quarter, as much as 1.03% of shares were owned by Foreign Portfolio Investors (FPI) whereas 0.13% and 0.4% of shares were owned by banks and mutual funds respectively. The promoter group retained 6.29% of equity while a net 93.71% was held by the public.

The characteristics of the ownership of firms such as these would be suggestive of the great interest investors have in the company, reshaping expectations for growth. Owing to the impressive financial results, continued development, and attractive strategies for raising resources, Evexia Lifecare is positioned to take advantage of prospects available in the healthcare sector.

Story first published: Tuesday, October 1, 2024, 15:12 [IST]